SynDRA canonical compound SYN0020322 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|---|
| Approval status | Approved · OTC |
| Primary target(s) | SLC12A1 |
| Mechanism of action | Sodium/potassium/chloride transporter inhibitor |
| Indication | acute glomerulonephritis (AGN) | chronic renal failure | congestive heart failure | edema | hepatic cirrhosis | hypertension | nephrotic syndrome |
| Disease area | cardiology | gastroenterology | nephrology | rheumatology |